1 2 3 4 5 6 7 8 9 10
The industry's premier human antibody discovery and optimization platform defined by speed, diversity, and quality
06.21.17Press Release
Adimab Provides Mid-Year Update on 2017 Partnership Activity
02.27.17Press Release
Arsanis and Adimab Enter Into License Agreement to Target Respiratory Syncytial Virus (RSV) With Monoclonal An…
02.23.17Press Release
Adimab Publishes Biophysical Performance Metrics that Predict Drug-like Properties of Antibody-based Therapeut…
01.10.17Press Release
Adimab Provides Annual Update on 2016 Partnerships and Milestones
12.09.16Press Release
Adimab Scientists Report the Isolation of Highly Potent anti-RSV Antibodies